Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...

CLEVELAND, Ohio — Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear — the eggs used to make the flu vaccine are safe.

Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...

Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Management provided guidance of $115 million in U.S. BRIUMVI net revenue for Q1 2025 and reiterated the full-year 2025 target of $525 million. January and February 2025 were noted as the highest ...

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

The end of the last decade brought record highs in pharmaceutical M&A as larger companies turned again and again to young biotechs for innovation. Often, these deals focused on cancer, rare diseases ...